DocSym
β
Searchsearch
Search
(D02.1) Carcinoma in situ: trachea
More details coming soon
45 605 in individuals diagnosis carcinoma in situ: trachea confirmed
6 065 deaths with diagnosis carcinoma in situ: trachea
13% mortality rate associated with the disease carcinoma in situ: trachea
Diagnosis carcinoma in situ: trachea is diagnosed Men are 42.27% more likely than Women
32 442
Men receive the diagnosis carcinoma in situ: trachea
792 (2.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
13 163
Women receive the diagnosis carcinoma in situ: trachea
5 273 (40.1 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: trachea - Men aged 60-64 and Women aged 55-59
In Men diagnosis is most often set at age 0-9, 15-29, 40-94
Less common in men the disease occurs at Age 0-1, 10-14, 30-39, 95+Less common in women the disease occurs at Age 0-1, 5-9, 30-39, 90-95+
In Women diagnosis is most often set at age 0-5, 10-29, 40-89
Disease Features carcinoma in situ: trachea
Absence or low individual and public risk
Carcinoma in situ: trachea - what does this mean
Carcinoma in situ of the trachea occurs when abnormal cells grow on the inner lining of the trachea and do not spread to other parts of the body. these cells can eventually become cancerous if left untreated.
What happens during the disease - carcinoma in situ: trachea
Carcinoma in situ of the trachea is an early stage of cancer in which abnormal cells are present in the lining of the trachea, however, the cells have not yet spread to other parts of the body. it is believed that this condition is caused by an accumulation of genetic mutations in the cells of the trachea, which can be caused by environmental factors such as smoking, radiation, and exposure to certain chemicals. in some cases, it can also be caused by an inherited genetic mutation.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Perform an imaging test, such as an X-ray, CT scan, or MRI, to assess the location and size of the tumor.
- Perform a biopsy to confirm the presence of cancer cells.
- Perform a bronchoscopy to examine the trachea and surrounding area.
- Perform a laryngoscopy to assess the vocal cords and surrounding area.
- Perform a thoracoscopy to examine the lungs and surrounding area.
- Perform a bronchography to assess the trachea and surrounding area.
- Perform a tracheal wash to collect cells from the trachea for analysis.
- Perform a tracheal aspiration to collect fluid from the trachea for analysis.
- Perform a tracheal biopsy to collect tissue from the trachea for analysis.
Treatment and Medical Assistance
Main Goal: To treat Carcinoma in situ of the Trachea
- Consultation with a medical team, including an oncologist, pulmonologist, and thoracic surgeon.
- Assessment of the extent of the cancer, including imaging tests.
- Surgery to remove the affected area of the trachea.
- Chemotherapy and/or radiation therapy to kill any remaining cancer cells.
- Regular follow-up visits to monitor for recurrence.
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: trachea - Prevention
Carcinoma in situ of the trachea can be prevented by avoiding smoking, eating a balanced diet with plenty of fruits and vegetables, avoiding second-hand smoke, and getting regular check-ups with your doctor. additionally, avoiding exposure to certain chemicals, such as asbestos, can help reduce the risk of developing carcinoma in situ of the trachea.